Plasmanyl vs. Plasmenyl Lipids: LC-MS Identification and Vinyl-Ether Confirmation

An LC-MS feature should not be called a plasmalogen simply because its accurate mass is consistent with an ether-linked phospholipid. Ether glycerophospholipids include plasmanyl species with an alkyl ether at the sn-1 position and plasmenyl species with an alk-1-enyl, or vinyl ether, linkage. The latter are plasmalogens. Moving from “ether lipid detected” to a specific P- or O-structure therefore requires evidence for the bond type as well as the headgroup and side-chain composition.

This distinction is consequential in studies of peroxisomal ether-lipid synthesis, membrane remodeling and oxidative stress. A decrease in a reported PE plasmalogen can represent true loss of the vinyl-ether species, conversion between ether-lipid pools, oxidation during sample handling, or misassignment of an isomeric plasmanyl lipid. The experiment must be designed to separate those explanations rather than resolving them after statistical analysis.

The analytical workflow should establish what reversed-phase LC, HILIC, high-resolution MS/MS, targeted SRM/PRM, and chemical confirmation can support. Projects requiring molecular-species measurement can use the plasmalogen analysis service, with the study design specifying the required structural evidence, stability controls, and quantitative scope.

Plasmanyl and Plasmenyl Lipid Nomenclature and Reporting Levels

The term “plasmalogen analysis” can describe several different measurements. They do not require the same standards, separation or degree of structural confirmation.

A discovery study may begin with ether-lipid candidates and later confirm a smaller target set. A pathway study comparing plasmanyl precursors with plasmenyl products needs both pools measured under a common extraction and response model. A targeted assay for predefined P-PE species requires a narrower but more rigorously validated transition and calibration scheme. Defining the endpoint first prevents a broad untargeted feature table from being presented as structure-specific quantification.

The biological denominator must also be specified. Ether-lipid amount per milligram of tissue, per defined cell number, per milligram of protein and mol% within the corresponding PC or PE class answer different questions. Class composition can change while the total pool remains stable, and an apparently stable mol% can mask a decrease in the entire phospholipid pool.

LC-MS Identification of Plasmanyl and Plasmenyl Lipids

Exact-Mass Limitations in Ether-Bond Assignment

The analytical ambiguity is illustrated by PE(O-18:1/20:4) and PE(P-18:0/20:4). One structure contains an unsaturated alkyl ether chain; the other contains a saturated carbon chain attached through a vinyl ether. The location of the unsaturation differs, but the elemental composition can be the same. An accurate precursor mass can therefore establish an ether-compatible formula without proving whether the double bond is the defining alk-1-enyl bond of a plasmalogen.

The same caution applies to sum compositions. Under current lipid shorthand rules, O- indicates an alkyl ether and P- indicates a proven alk-1-enyl linkage. An exported software name should be capped at the evidence acquired. Biological plausibility—such as the predominance of P-PE in a particular tissue—is not a substitute for analytical confirmation, especially in perturbed models where ether-lipid metabolism may no longer resemble the control state.

Figure 1. Plasmanyl and plasmenyl phospholipids differ at the sn-1 linkage. Redistribution of the same unsaturation between the ether chain and vinyl-ether bond can create isomeric species that are not resolved by precursor mass alone.

Method-Specific Retention of Plasmanyl and Plasmenyl Lipids

Reversed-phase retention contains useful structural information because chain length, conventional unsaturation and a vinyl-ether bond do not alter hydrophobicity in identical ways. Work using plasmalogen-deficient and plasmanyl-enriched mouse material showed a reproducible retention-time offset between matched plasmanyl and plasmenyl species. This provides a practical route to P-/O-discrimination without requiring a specialized activation platform.

The rule is method dependent. Column chemistry, gradient, temperature, solvent additives and adduct form all affect retention. A published time offset should not be copied as a universal identification window. The laboratory should establish a homologous retention series with standards or well-characterized reference material, then test whether the rule remains valid across headgroups and the chain-length range used in the study. Closely eluting peaks require adequate sampling across the peak and review of extracted-ion chromatograms rather than reliance on a software apex.

HILIC provides a different form of selectivity. It can separate headgroup classes and, under optimized conditions, may separate ether subclasses. This is valuable for class-oriented profiling and reduction of interclass interference. It does not automatically resolve every plasmanyl/plasmenyl molecular-species pair because members of the same class can coelute. Method selection should distinguish class separation from bond-type confirmation.

Fragment-Ion Evidence for Ether-Lipid Side-Chain Assignment

Negative-ion MS/MS of ether PE can provide the sn-2 fatty-acyl anion and neutral-loss or lysophospholipid-related products. PC often requires an anionic adduct or polarity switching to obtain comparable side-chain information, while the phosphocholine product is useful for class confirmation in positive mode. Multiple transitions that share a chromatographic apex can strengthen the assignment of a targeted species.

However, some isomeric plasmanyl and plasmenyl pairs produce highly similar collision-induced dissociation spectra. A fragment supporting the sn-2 acyl chain does not necessarily locate the remaining double bond in the sn-1 chain. Diagnostic fragments should therefore be classified by the information they actually provide: headgroup, fatty-acyl composition, ether-chain composition, or vinyl-ether evidence.

Isotopes, Adducts, and In-Source Products

The candidate list also requires feature-level cleanup before structural interpretation. PC ether lipids may appear as protonated ions in positive mode and as formate- or acetate-containing adducts in negative mode. The same molecule can therefore generate several features, while different lipids can contribute signal within a narrow mass window. Isotopic peaks from an abundant neighboring phospholipid can inflate a low-abundance ether-lipid feature if the isotope envelope and chromatographic peak are not evaluated together.

Adduct grouping should require aligned retention time and peak shape, not mass differences alone. Product-ion spectra should be inspected for co-isolation, particularly when a broad isolation window contains a high-abundance diacyl phospholipid. A qualifier transition that varies independently of the quantifier across samples is a warning for interference rather than evidence of biological remodeling. Where in-source products are plausible, source-energy experiments and precursor–product chromatographic alignment can establish whether the signal existed in the sample or formed during ionization.

Automated libraries remain useful for candidate generation, but scoring does not override chemical evidence. Search output should retain the alternative P-/O-interpretations until the validated retention, fragment or chemical-confirmation rule is applied. Manual review should prioritize features that are low abundance, statistically influential, poorly resolved, or central to the proposed mechanism.

Orthogonal Confirmation of the Vinyl-Ether Bond

No single platform is optimal for discovery coverage, bond-type certainty and high-throughput quantification. A staged design can use broad profiling to identify relevant ether-lipid candidates, confirm the P-/O-identity of selected targets and then transfer those targets to a quantitative assay.

Mild acid hydrolysis and acidic methanolysis should not be described as the same experiment. In a paired hydrolysis test, disappearance of an LC-MS feature relative to an untreated aliquot supports an acid-labile vinyl ether. In acidic methanolysis, cleavage products are converted to dimethyl acetals for GC analysis. DMA composition confirms the presence and sn-1 chain distribution of plasmalogens but generally does not preserve the one-to-one connection to the original sn-2 fatty acid in each intact molecule.

Chemical confirmation is most useful when the primary conclusion depends on the P-/O-balance, when authentic intact standards are unavailable, or when an unexpected biological model may accumulate plasmanyl precursors. It need not be applied to every sample in a large cohort. A representative subset, pooled reference material and relevant controls can establish the structural rule before the validated LC-MS method is applied at scale.

Targeted analysis is appropriate after the relevant structures are defined. The targeted lipidomics service can support a restricted panel, but the transition list should be designed from the required evidence rather than copied from a generic lipid library. Quantifier and qualifier transitions, retention windows, isotopic interference and potential in-source fragments should be reviewed for every reported target.

Figure 2. Evidence workflow for ether-lipid studies. Discovery LC-MS identifies candidates, validated retention and product ions establish molecular species, and chemical or biological reference evidence supports the P-/O-bond assignment before targeted quantification.

Preventing Plasmalogen Oxidation During Sample Handling

The vinyl-ether bond is acid labile and susceptible to several oxidative reactions. Polyunsaturated plasmalogens also contain an oxidation-sensitive sn-2 chain. Parent loss can therefore occur through more than one reaction pathway, and the products retained by the analytical method will depend on the oxidant, matrix and handling conditions.

Cold and rapid processing, limited exposure to air and light, clean glassware and controlled evaporation reduce avoidable loss. Antioxidants and metal chelators may be useful, but no additive concentration should be treated as universal. The additive must be evaluated for the intended plasmalogens, expected oxidation products, ionization mode and downstream chemical confirmation. Acidification introduced to improve recovery of another lipid class can be incompatible with intact plasmalogen measurement.

A stability assessment should model the actual study rather than a convenient generic condition. A pooled matrix can be divided before processing into a reference aliquot and realistic challenges: delayed freezing, an additional freeze–thaw cycle, prolonged homogenization, extended evaporation, or the maximum anticipated autosampler residence. The evaluation should monitor susceptible parent P-PE and P-PC species, representative plasmanyl lipids, lysophospholipids and detectable oxidation or cleavage products.

The interpretation depends on correlated changes. A decreasing parent with a time-dependent rise in related products supports degradation. Stable total PC or PE does not demonstrate plasmalogen stability because the affected molecules may represent a small fraction of the class. Repeated freeze–thaw has been shown to accelerate plasmalogen loss in a storage model, with the largest effects in polyunsaturated ethanolamine plasmalogens. The magnitude cannot be transferred directly to plasma, cultured cells or other tissues, but the finding supports matrix-specific freeze–thaw testing.

At minimum, the analytical batch should contain:

• process blanks taken through extraction, evaporation and reconstitution;
• solvent blanks placed to reveal carryover after concentrated samples;
• a pooled biological QC representing the study matrix;
• extraction replicates to separate preparation variance from injection variance;
• randomized biological groups across extraction and injection order;
• pre-extraction internal standards for recovery and processing loss;
• post-extraction spikes, where practical, to assess ion suppression independently of recovery.

For studies that interpret oxidative consumption, the same extraction should measure parent plasmalogens and the selected products. If the products are too unstable or structurally heterogeneous for reliable measurement, the conclusion should be limited to parent depletion under validated handling conditions rather than a specific oxidation mechanism.

Quantitation After Structural Assignment

Ether-lipid response depends on headgroup, chain length, unsaturation, adduct formation, chromatographic position and matrix. One class standard can normalize injection variability and part of the extraction loss, but it cannot demonstrate equal response across all plasmanyl and plasmenyl species. This limitation is particularly important when comparing P-PC with P-PE or a saturated sn-2 species with a highly polyunsaturated species.

The quantitative language should follow the calibration model:

• Relative profiling reports internal-standard-normalized peak areas under a common workflow. It supports group comparison but not molar concentration.
• Class-based semiquantification applies a response factor from one or more representative standards. Values are estimates and should identify the shared-response assumption.
• Species-specific quantification uses an authentic or adequately matched calibrator with a demonstrated range, selectivity, recovery, matrix effect, precision and stability.
• Orthogonal total plasmalogen measurement estimates class content through vinyl-ether-selective chemistry or DMA analysis, but it does not replace intact molecular-species quantification.

The time of internal-standard addition should be reported. Addition before extraction can track preparation loss; addition only before injection cannot. A non-endogenous plasmalogen with similar headgroup and retention is preferable to a distant diacyl phospholipid, but even a structural analog may not reproduce every analyte's oxidation and response. If standards are available for only a subset, directly calibrated species should be separated from estimated species in the result table.

Units also define the claim. Amount per tissue mass, protein, DNA or cell number describes sample-normalized abundance. Mol% within PE or PC describes composition. P-/O-ratios describe remodeling balance but can rise because the numerator increases, the denominator decreases, or both. Ratios should always be accompanied by their components on the same normalization scale.

Broader membrane context can help determine whether an apparent P-/O-shift is selective. A focused phospholipid profiling service can measure the corresponding diacyl PC and PE pools and related lysophospholipids. This is useful when a change in P-PE mol% could otherwise reflect contraction of the diacyl denominator rather than expansion of the plasmalogen pool.

Reporting Confidence for Plasmanyl and Plasmenyl Assignments

The final feature table should show more than a lipid name and fold change. For each reported ether lipid, it should include the precursor/adduct, retention time, supported structural level, product-ion evidence, P-/O-confirmation route, internal standard, quantification tier, normalization denominator, QC precision and missingness. Flags should distinguish a feature below the calibrated range from a structurally ambiguous feature; both should not be converted silently to zero.

Names must remain consistent throughout the chromatogram, statistics and figures. A candidate reported as an unresolved ether sum composition in the primary table should not become a fully specified plasmalogen in a pathway plot. When an authentic standard confirms retention and transitions, that evidence should be stated. When P-assignment rests on a validated retention rule or paired chemical treatment, the rule and reference material should be documented.

Interpretation should preserve pool size and composition simultaneously. Report total measured P-PC and P-PE, the individual molecular species, the corresponding plasmanyl pools when relevant, and the P-/O-components behind each ratio. Parent plasmalogen loss should not be labeled oxidative consumption unless handling stability and the chosen product evidence support that mechanism. Likewise, a shift in the ether-lipid profile does not by itself establish altered peroxisomal synthesis without suitable pathway measurements.

The final interpretation should state which ether-lipid pools changed, which molecular species were supported, which P-/O-assignments were confirmed, and how extraction, matrix, and calibration affected those results. Conclusions should remain limited to assignments supported by stability controls, matrix assessment, and calibration rather than the total number of features labeled “plasmalogen.”

References:

1. Liebisch, G., Fahy, E., Aoki, J., et al. Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures. Journal of Lipid Research. 2020;61(12):1539–1555. https://doi.org/10.1194/jlr.S120001025.
2. Koch, J., Lackner, K., Wohlfarter, Y., et al. Unequivocal mapping of molecular ether lipid species by LC-MS/MS in plasmalogen-deficient mice. Analytical Chemistry. 2020;92(16):11268–11276. https://doi.org/10.1021/acs.analchem.0c01933.
3. Azad, A. K., Kobayashi, H., Sheikh, A. M., et al. Rapid identification of plasmalogen molecular species using targeted multiplexed selected reaction monitoring mass spectrometry. Journal of Mass Spectrometry and Advances in the Clinical Lab. 2021;22:26–33. https://doi.org/10.1016/j.jmsacl.2021.09.004.
4. Hui, S. P., Chiba, H., & Kurosawa, T. Liquid chromatography-mass spectrometric determination of plasmalogens in human plasma. Analytical and Bioanalytical Chemistry. 2011;400(7):1923–1931. https://doi.org/10.1007/s00216-011-4921-7.
5. Otoki, Y., Kato, S., Kimura, F., et al. Accurate quantitation of choline and ethanolamine plasmalogen molecular species in human plasma by liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2017;134:77–85. https://doi.org/10.1016/j.jpba.2016.11.019.
6. Morel, Y., Hegdekar, N., Sarkar, C., et al. Structure-specific, accurate quantitation of plasmalogen glycerophosphoethanolamine. Analytica Chimica Acta. 2021;1186:339088. https://doi.org/10.1016/j.aca.2021.339088.
7. Pham, T. H., Zaeem, M., Fillier, T. A., et al. Targeting modified lipids during routine lipidomics analysis using HILIC and C30 reverse phase liquid chromatography coupled to mass spectrometry. Scientific Reports. 2019;9:5048. https://doi.org/10.1038/s41598-019-41556-9.
8. Fhaner, C. J., Liu, S., Zhou, X., & Reid, G. E. Functional group selective derivatization and gas-phase fragmentation reactions of plasmalogen glycerophospholipids. Mass Spectrometry. 2013;2:S0015. https://doi.org/10.5702/massspectrometry.S0015.
9. Delmonte, P., et al. Separation and characterization of products from acidic methanolysis of plasmalogenic lipids by two-dimensional gas chromatography with online reduction. Journal of Chromatography A. 2020;1617:460955. https://doi.org/10.1016/j.chroma.2020.460955.
10. Chen, Z., Jia, J., Wu, Y., Chiba, H., & Hui, S. P. LC/MS analysis of storage-induced plasmalogen loss in ready-to-eat fish. Food Chemistry. 2022;383:132320. https://doi.org/10.1016/j.foodchem.2022.132320.
11. Vasku, G., Acar, N., & Berdeaux, O. Rapid analysis of plasmalogen individual species by high-resolution mass spectrometry. Methods in Molecular Biology. 2023;2625:259–267. https://doi.org/10.1007/978-1-0716-2966-6_22.